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Abstract
Background: recognising that a patient is nearing the end of life is essential, to enable professional carers to discuss prog-
nosis and preferences for end of life care.
Objective: investigate whether an electronic frailty index (eFI) generated from routinely collected data, can be used to pre-
dict mortality at an individual level.
Design: historical prospective case control study.
Setting: UK primary care electronic health records.
Subjects: 13,149 individuals age 75 and over who died between 01/01/2015 and 01/01/2016, 1:1 matched by age and sex
to individuals with no record of death in the same time period.
Methods: two subsamples were randomly selected to enable development and validation of the association between eFI 3
months prior to death and mortality. Receiver operator characteristic (ROC) analyses were used to examine diagnostic accur-
acy of eFI at 3 months prior to death.
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Results: an eFI > 0.19 predicted mortality in the development sample at 75% sensitivity and 69% area under received oper-
ating curve (AUC). In the validation dataset this cut point gave 76% sensitivity, 53% speciﬁcity.
Conclusions: the eFI measured at a single time point has low predictive value for individual risk of death, even 3 months prior
to death. Although the eFI is a strong predictor or mortality at a population level, its use for individuals is far less clear
Keywords: frailty, palliative care, end of life care, primary care, older people
Introduction
Improving the experiences of those nearing the end of life is a
global public health imperative [1, 2]. Early identiﬁcation of this
stage of an individual’s life is an essential step to achieving this
goal: patients who are identiﬁed earlier have the opportunity to
discuss preferences and make advance plans for care [3–5].
Frailty has been identiﬁed as a common condition associated
with death in community-dwelling older people [6] and reﬂects
a state of increased vulnerability to poor resolution of hom-
oeostasis after a stressor event. This state is associated with an
increased risk of adverse outcomes, including falls, delirium,
disability, care home admission, hospitalisation and mortality
[7–10]. In high income countries approximately 11% of peo-
ple over 65 years and 25–50% of those over 85 years have
frailty [11].
Recognising frailty and its extent in clinical practice may
be challenging [12]. An electronic frailty index (eFI) has been
developed using electronic primary healthcare records in
England to help clinicians identify patients who are living
with frailty [10]. The index uses a cumulative deﬁcit model [13]
to calculate a frailty score based on a range of symptoms,
diagnoses and observations recorded by family physicians. From
July 2017, GP practices in England will be required to identify
and monitor patients with moderate and severe frailty using a
validated frailty instrument. As the eFI is now available on the
desktops of a majority of general practitioners in England, it is
likely to be widely used to identify patients with frailty.
Increasing levels of frailty are strongly associated with risk
of mortality when measured at a single point in time [14–16],
but there has been little research investigating the utility of
measures of frailty to predict mortality in individuals. This is
important, because clinicians need to anticipate death in order
to target palliative and end of life care resources. In this study,
our aim was to test the hypothesis that the eFI generated from
routinely collected data, can be used to predict mortality at an
individual level.
Method
Setting
This study used electronic health record data from ResearchOne,
a health and care research database containing de-identiﬁed
clinical and administrative data from approximately six million
active electronic healthcare records (EHRs). ResearchOne
extracts anonymised data from the SystmOne clinical informa-
tion system, which is used in over 2500 primary care practices
in England. General practitioners use SystmOne to record
their consultations (including patient histories, clinical observa-
tions, diagnoses, treatments and referrals) with free text and
the Read code classiﬁcation system [17].
Study design
In this historical prospective case control study, probability
of mortality was determined using eFI scores calculated 3
months prior to recorded month of death in decedents and 3
months prior to 1 January 2016 for matched survivors. This
3-month window was selected to maximise the ability of the
eFI to discriminate between decedents and survivors, whilst
still allowing clinicians sufﬁcient opportunity to intervene in
patients’ end of life management.
Participants
ResearchOne identiﬁed records of individuals (decedents) age
75 and over who died between 01/01/2015 and 01/01/2016.
This age group was selected because the study aim was predic-
tion of mortality to inform the need for palliative and end of life
care, and the majority of deaths occur in this age group.
Furthermore, it has been established that older people are less
likely to access specialist palliative care services [18]. A compari-
son group (survivors) was constructed by identifying patients
matched to decedents by age, sex and practice location, but with
no record of death between 01/01/2015 and 01/01/2016.
Data were not extracted on individuals with records available
for fewer than 6 months, and where cause of death was classiﬁed
as an external cause of mortality (International Classiﬁcation of
Diseases codes version 10). Due to the method of sampling,
controls were matched at age of death of the case (between
01/01/2015 and 01/01/2016), but their data was collected
on 01/01/2016, when they were known to have not have
died during the sampling period; this caused the controls to
be on average 6 months older than the cases at measurement.
Test methods
The eFI is a cumulative deﬁcit measure of frailty that calcu-
lates a frailty score based on 36 deﬁcits, drawn from a pool of
2000 clinical Read codes for symptoms, signs, diseases, disabil-
ities and abnormal laboratory test values [10]. An individual’s
eFI score is calculated by dividing the number of deﬁcits pre-
sent by the total possible to create a score between 0 (no deﬁ-
cits) and 1 (36 deﬁcits). Severity categories (0–0.12 = ﬁt;
>0.12–0.24 = mild frailty; >0.24–0.36 = moderate frailty;
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>0.36 = severe frailty) are deﬁned using quartiles, with the
99th centile as the upper limit [10].
Analysis
The ResearchOne dataset was split at random without replace-
ment into a development dataset of 70% of cases and a valid-
ation dataset of 30% of cases.
Characteristics of the development and validation dataset
cohorts were calculated as frequencies and univariate analyses
were used to examine group differences. Unconditional logis-
tic regression was used to examine the association between
severe frailty (eFI > 0.36) and mortality in the development
dataset, adjusted for matching variables age and sex. To enable
predictions appropriate for the complete population, survivors
were reweighted (using inverse probability weights calculated
using Ofﬁce of National Statistics life tables for 2013–16) to
reﬂect the population size adjusting for deaths.
Weighted and unweighted receiver operating characteristic
(ROC) curves were created and exploratory sensitivity analyses
were used to determine an optimum cut point for frailty asso-
ciated with an increased risk of death, with a target sensitivity
of 75%. We chose to propose that the speciﬁcity of the test
was less important as the questions about end of life care
would be acceptable even to those who do not die within a
short time. The optimum cut point was then tested in the val-
idation dataset. All sensitivity analyses were repeated stratiﬁed
by sex and age using 74–84, 85–94, 95+ age strata. All ana-
lyses were controlled for the matching variables, with age
mean centred. An alpha level of <0.05 was used to signify
conventional statistical signiﬁcance. Analyses were performed
using R, CRAN version 3.3.2 [19] (PRROC [20], Survey [21])
Results
Participants
In total, 13,149 decedents age > 75 were identiﬁed by
ResearchOne and matched to 13,149 survivors. Table 1 con-
trasts demographic characteristics of the 9,204 decedents in
the development dataset and the 3,945 decedents in the valid-
ation dataset versus matched survivors. The development
dataset contained 4,116 (44.7%) males and 5,088 (55.3%)
females. The mean age was 85.1 (SD 6.0) years for decedents
and 85.7 (SD 6.0) years for survivors, as expected by design.
Mean eFI was signiﬁcantly higher (P < 0.0001) for decedents
(0.29, SD 0.11) than for survivors (0.25, SD 0.11), and mean
eFI for females overall (0.28, SD 0.12) was signiﬁcantly higher
(P < 0.0001) than for males (0.25, SD 0.11).
Test results
Development sample
An unweighted logistic regression model with ‘not frail’ as the
reference category (Table 2), showed that increasing severity
of frailty is strongly associated with higher odds of mortality
(severe frailty OR 4.30 95%CI 3.84–4.89). The inverse prob-
ability weighted logistic regression model (Table 2) showed a
similar strong association between the frailty category and
odds of mortality (severe frailty OR 4.72 95%CI 4.16−5.36).
In an unweighted ROC the area under the curve was
0.62; adjusting for population size with the weighted ROC
analysis the area under the curve was 0.69 (Supplementary
Figure 1 available at Age and Ageing online). Severe frailty as
a predictor of mortality had a sensitivity of 23% (95% CI
22–24%) and a speciﬁcity of 91% (95% CI 91–91%). In age
and sex speciﬁc analysis, optimum cut points were proposed
in the range of mild severity (0.17–0.22) with higher values for
the females and for older age strata (Table 3).
Validation sample
In the validation sample, across all strata these cut points over-
estimate the prevalence of death and identify over 50% of the
sample as being at risk of death where the true values for
prevalence lie in the range of 4–37% (Table 3).
Discussion
This study has shown that a single frailty measure has a low
predictive value for mortality at an individual level, even close
to death. Although the eFI is a strong predictor or mortality
at a population level, its use for individuals is far less clear and
our ﬁndings emphasise the need to understand the application
of individual measures of frailty, if they are in widespread use
in primary care. Using our proposed optimal cutoff to predict
mortality in individuals would overestimate the number of
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Characteristics of individuals in the development
and validation datasets. Decedents at 3 months prior to
death and their matched survivors at the same time point.
Development sample Validation sample
Decedents Survivors Decedents Survivors
Age: years, mean (SD) 85.1 (6.0) 85.7 (6.0) 85.1 (6.0) 85.6 (6.0)
Gender
Male, n (%) 4,116 (44.7) 4,116 (44.7) 1,723 (43.7) 1,723 (43.7)
Female, n (%) 5,088 (55.3) 5,088 (55.3) 2,222 (56.3) 2,222 (56.3)
Overall eFI: mean (SD) 0.29 (0.11) 0.25 (0.11) 0.29 (0.11) 0.24 (0.11)
Male eFI: mean (SD) 0.28 (0.11) 0.23 (0.11) 0.28 (0.11) 0.23 (0.11)
Female eFI: mean (SD) 0.30 (0.11) 0.26 (0.12) 0.30 (0.11) 0.26 (0.11)
Frailty category
Not frail, n (%) 563 (6.1) 1,245 (13.5) 262 (6.6) 545 (13.8)
Mild, n, (%) 2,517 (27.3) 3,386 (36.8) 1,043 (26.4) 1,478 (37.5)
Moderate, n (%) 3,355 (36.5) 2,856 (31.0) 1,461 (37.0) 1,216 (30.8)
Severe, n (%) 2,769 (30.1) 1,717 (18.7) 1,179 (29.9) 706 (17.9)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. The association (odds ratio, OR) between severity
of frailty and mortality 3 months prior to death: results
from logistic regression models in the development sample.
OR2 95% CI P OR3 95% CI P
1Mild frailty 1.76 [1.57−1.97] <0.0001 1.80 [1.60−2.02] <0.0001
1Moderate frailty 3.00 [2.68−3.37] <0.0001 3.19 [2.83−3.59] <0.0001
1Severe frailty 4.30 [3.84−4.89] <0.0001 4.72 [4.16−5.36] <0.0001
1Reference category is ‘not frail’; 2unweighted; 3 inverse probability weighted.
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individuals at risk of dying, and could lead to inappropriate
targeting of resources.
There are a growing number of initiatives to increase
awareness of frailty and improve patient outcomes [22, 23]. In
England, a requirement to identify adults with moderate and
severe frailty is being introduced into the GP contract from
the middle of 2017. This will require an easy to use tool to
identify patients with frailty nearing the end of life, and predict
their likely future care needs. Several studies have demon-
strated an association between frailty and risk of mortality and
increased service utilisation [10, 24, 25, 26]. However, these
studies have not examined the predictive utility of frailty scores
on an individual basis. This study builds on previous ﬁndings
by focussing speciﬁcally on frailty in the last year of life in an
unselected primary care population, using a measure of frailty
that is routinely available.
Strengths and limitations
The use of large primary care cohort is a major strength of
this study. Data in ResearchOne are demographically and geo-
graphically representative of the population in England.
Because the data are recorded by general practitioners as part
of routine care, many of the limitations of survey data, such as
cost, non-response or attrition due to ill health, are overcome.
The study design as implemented by ResearchOne gener-
ated the potential pool of controls at a ﬁxed time point (con-
trols had to be alive on 01/01/2016), rather than identify a
control when every case died between the study period. This
design created an imbalance of age where the controls were
older than the cases, however as frailty increases with age, and
age was used as an adjustment this is unlikely to have affected
the results. In addition, no individual could be both a control
and then later a case due to the independence of the two sam-
pling mechanisms.
Study exclusion criteria were applied at the point of data
extraction and no data were available on the numbers of indi-
viduals who were not eligible for study entry. We were unable
to comment on instances where no eFI score was available,
but we expect this to be a negligible number.
Previous studies suggest that cumulative deﬁcit models of
frailty have better predictive power than phenotypic models
[27–29]. The eFI has been validated in a large population
using two different electronic healthcare record systems [10],
but we cannot be sure that our ﬁndings would be replicated
with a different frailty index.
Recent work has examined longitudinal annual changes in
frailty and identiﬁed distinct trajectories of frailty associated
with higher levels of healthcare utilisation [30]. These ﬁndings
suggest the possibility that longitudinal changes in frailty
scores could be used to target individuals at risk of hospitalisa-
tion or death. Future studies should investigate whether dis-
tinct trajectories of frailty exist over a shorter time frame, and
whether these trajectories could help to indicate to physicians
where a patient may have palliative or end of life care needs,
improving the speciﬁcity without jeopardising the sensitivity.
Implications for practice
For individuals, single time point frailty scores alone are not a
strong predictor of mortality, even 3 months prior to death.
Further work is needed to examine whether longitudinal
change in frailty scores can better predict end of life care needs
in older adults.
Key points
• There is a strong association between severity of frailty and
mortality.
• Few studies have attempted to determine the predictive
value of frailty scores for mortality at an individual level.
• We have shown that a single frailty score, calculated close to
death has low predictive value for mortality in older adults.
• Understanding of the application of individual measures
of frailty is essential, if they are in widespread use in pri-
mary care.
Supplementary data
Supplementary data mentioned in the text are available to sub-
scribers in Age and Ageing online.
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Abstract
Background: there is evidence suggesting that several chronic diseases have their origins in utero and that development
taking place during sensitive periods may affect the aging process. We investigated whether early life determinants would be
associated with frailty in old age.
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